InsidersTradesSigma
Follow the 博雅生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 博雅生物 has recorded 1 reports. Market capitalisation: €7.8bn. The latest transaction was reported on 16 June 2021 (Purchase). Among the most active insiders: 梁小明. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
博雅生物 is a company specializing in the health and pharmaceutical sector, listed on the XSHE market. It focuses on developing innovative biopharmaceutical solutions.